BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36187131)

  • 1. The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism.
    Basińska-Lewandowska M; Lewiński A; Lewandowski KC; Skowrońska-Jóźwiak E
    Front Endocrinol (Lausanne); 2022; 13():1013362. PubMed ID: 36187131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.
    Wang X; Meng L; Su C; Shapses SA
    Endocr Pract; 2020 Feb; 26(2):174-178. PubMed ID: 31557077
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
    Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
    Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
    Majid H; Khan AH; Riaz M; Karimi H; Talati J
    Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
    Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
    Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
    Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
    Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
    Guo Y; Wang Q; Lu C; Fan P; Li J; Luo X; Chen D
    BMC Endocr Disord; 2020 Jan; 20(1):5. PubMed ID: 31914999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
    Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy.
    Vignali E; Cetani F; Chiavistelli S; Meola A; Saponaro F; Centoni R; Cianferotti L; Marcocci C
    Endocr Connect; 2015 Sep; 4(3):172-8. PubMed ID: 26155986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between 25-hydroxyvitamin D concentrations, serum calcium, and parathyroid hormone in apparently healthy Syrian people.
    Sayed-Hassan R; Abazid N; Alourfi Z
    Arch Osteoporos; 2014; 9():176. PubMed ID: 24715441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure.
    Melin A; Wilske J; Ringertz H; Sääf M
    J Am Geriatr Soc; 2001 Sep; 49(9):1190-6. PubMed ID: 11559378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
    Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normocalcemic primary hyperparathyroidism: an update.
    Salcuni AS; Battista C; Pugliese F; Columbu C; Guarnieri V; Carnevale V; Scillitani A
    Minerva Endocrinol (Torino); 2021 Sep; 46(3):262-271. PubMed ID: 33103871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum vitamin D insufficiency and secondary hyperparathyroidism in healthy Danish women.
    Møller UK; Ramlau-Hansen CH; Rejnmark L; Heickendorff L; Henriksen TB; Mosekilde L
    Eur J Clin Nutr; 2006 Oct; 60(10):1214-21. PubMed ID: 16721399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.
    Touvier M; Deschasaux M; Montourcy M; Sutton A; Charnaux N; Kesse-Guyot E; Fezeu LK; Latino-Martel P; Druesne-Pecollo N; Malvy D; Galan P; Hercberg S; Ezzedine K; Souberbielle JC
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1196-203. PubMed ID: 24527713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.